# US 2021/0195891 A1 · Cryopreservation of tissues and organs

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0195891 A1
- Document ID: US20210195891A1
- Status: Published application
- Kind: A1
- Application number: 17/058,279
- Filed: 2019-05-30
- Published: 2021-07-01
- Earliest claimed: 2018-05-30
- Assignees: The General Hospital Corporation
- Applicants: The General Hospital Corporation
- Inventors: Mustafa Korkut Uygun; Shannon Noella Tessier; Renier Johan de Vries
- Web page: https://patentgrep.com/patent/US20210195891A1

## CPC

- A01N 1/162: Temperature processes, e.g. following predefined temperature changes over time
- A01N 1/125: Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators
- A01N 1/143: for organ perfusion
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS

## Abstract

This disclosure is related to methods of preserving biological samples such as organs, and tissue. The present disclosure relates to methods of subzero preservation of biological tissue samples, such as entire organs from mammals, e.g., humans. The present disclosure is based, at least in part, on the discovery that biological tissue samples can be supercooled while minimizing formation of ice crystals by reducing liquid-air interfaces and lowering the melting point of the tissue samples, e.g., organs, or liquid in the tissue samples by use of cryoprotective agents while ensuring uniform distribution of cryoprotective agents throughout the biological sample by using improved perfusion techniques.

## Claims

### Claim 1

A method for preserving a biological sample, the method comprising:
(a) perfusing the biological sample at a first perfusion rate with a first loading solution comprising one or more cryoprotective agent(s) at a hypothermic temperature;
(b) perfusing the biological sample at a second perfusion rate lower than the first perfusion rate with a second loading solution comprising a higher concentration of at least one of the one or more cryoprotective agent(s) than in the first loading solution at a hypothermic temperature;
(c) placing the perfused biological sample in a container;
(d) removing sufficient air from the container to avoid ice crystal formation in cells within the biological sample or the loading solution, and sealing the container; and
(e) cooling the biological sample in the container to a subzero temperature, thereby preserving the biological sample at a subzero temperature.

### Claim 2 (depends on 1)

The method of claim 1, wherein the method further comprises, prior to step (a):
perfusing the biological sample with a pre-supercooling recovery solution comprising one or more cryoprotective agent(s) at a sub-normothermic temperature; and
perfusing the biological sample with the pre-supercooling recovery solution at a hypothermic temperature.

### Claim 3 (depends on 2)

The method of claim 2, wherein the perfusion step at a sub-normothermic temperature comprises supplementing the pre-supercooling recovery solution with insulin and one or more additional cryoprotective agent(s) during the perfusion step.

### Claim 4 (depends on 2)

The method of claim 2, wherein the perfusion step at sub-normothermic temperature comprises replacing the pre-supercooling recovery solution with a pre-supercooling recovery solution further comprising insulin and one or more additional cryoprotective agent(s) during the perfusion step.

### Claim 5 (depends on 1, 2, 3, 4)

The method of any one of claims 1-4, further comprising:
(f) perfusing the biological sample with an unloading solution comprising one or more cryoprotective agent(s) at a hypothermic temperature;
(g) perfusing the biological sample with a post-supercooling recovery solution comprising one or more cryoprotective agent(s) at a sub-normothermic temperature; and
(h) warming the biological sample to a normothermic temperature, thereby recovering the preserved biological sample for use.

### Claim 6 (depends on 1, 2, 3, 4, 5)

The method of any one of claims 1-5, wherein the first loading solution comprises one or more of the following cryoprotective agents: polyethylene glycol (PEG), glycerol, trehalose, and University of Wisconsin solution (UW).

### Claim 7 (depends on 1, 2, 3, 4, 5, 6)

The method of any one of claims 1-6, wherein the second loading solution comprises a higher concentration of glycerol than the first loading solution.

### Claim 8 (depends on 1, 2, 3, 4, 5, 6, 7)

The method of any one of claims 1-7, wherein the hypothermic temperature is between 0° C. and 12° C.

### Claim 9 (depends on 8)

The method of claim 8, wherein the hypothermic temperature is about 4° C.

### Claim 10 (depends on 1, 2, 3, 4, 5, 6, 7, 8)

The method of any one of claims 1-8, wherein the sub-normothermic temperature is between 12° C. and 35° C.

### Claim 11 (depends on 10)

The method of claim 10, wherein the sub-normothermic temperature is about 21° C.

### Claim 12 (depends on 5, 6, 7, 8, 9, 10, 11)

The method of any one of claims 5-11, wherein the normothermic temperature is greater than 35° C.

### Claim 13 (depends on 12)

The method of claim 12, wherein the normothermic temperature is about 37° C.

### Claim 14 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13)

The method of any one of claims 1-13, wherein the subzero temperature is about −4° C.

### Claim 15 (depends on 14)

The method of claim 14, wherein the subzero temperature is below −4° C., e.g., below −5° C., −6° C., −7° C., −8° C., −9° C., −10° C., −11° C., −12° C., −13° C., −14° C., −15° C., −16° C., −17° C., −18° C., −19° C., −20° C., −25° C., −30° C., −35° C., −40° C., or even lower temperature.

### Claim 16 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15)

The method of any one of claims 1-15, wherein the removal of sufficient air from the container results in elimination or reduction of one or more liquid-air interfaces in the container, thereby reducing or eliminating formation of ice crystals.

### Claim 17 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16)

The method of any one of claims 1-16, wherein the perfusion of the biological sample with the first loading solution and/or the second loading solution reduces the melting temperature of the liquid within the biological sample.

### Claim 18 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)

The method of any one of claims 1-17, wherein the biological sample remains unfrozen when cooled to a subzero temperature.

### Claim 19 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18)

The method of any one of claims 1-18, wherein the biological sample is an organ or tissue.

### Claim 20 (depends on 19)

The method of claim 19, wherein the organ is a donor organ for organ transplantation.

### Claim 21 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20)

The method of any one of claims 1-20, wherein the biological sample is obtained from a human, a primate, or a pig.

### Claim 22 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19)

The method of any one of claims 1-19, wherein the organ is a lab-grown organ.

### Claim 23 (depends on 22)

The method of claim 22, wherein the organ is a heart, kidney, bone, lung, eye, ovary, pancreas or any tissues that can be perfused through a vessel such as limbs and other vascular composite allografts.

### Claim 24 (depends on 23)

The method of claim 23, wherein the organ is a liver.

### Claim 25 (depends on 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24)

The method of any one of claims 2-24, wherein the pre-supercooling recovery solution further comprises one or more of insulin, dexamethasone, heparin, antibiotics, albumin, and Williams' medium E.

### Claim 26 (depends on 25)

The method of claim 25, wherein the pre-supercooling recovery solution comprises:
between 5 U and 20 U insulin per 1 L;
between 4 mg and 16 mg dexamethasone per 1 L;
between 2500 U and 10,000 U heparin per 1 L;
between 4 mL and 16 mL penicillin-streptomycin (5000 U/ml) per 1 L;
between 25 mL and 100 mL 25% human albumin per 1 L;
between 10 g and 40 g 35 kDa PEG; and
Williams' medium E.

### Claim 27 (depends on 26)

The method of claim 26, wherein the pre-supercooling recovery solution comprises:
about 10 U insulin per 1 L;
about 8 mg dexamethasone per 1 L;
about 5000 U heparin per 1 L;
about 8 mL penicillin-streptomycin (5000 U/ml) per 1 L;
about 50 mL 25% human albumin per 1 L;
about 20 g 35 kDa PEG; and
Williams' medium E.

### Claim 28 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27)

The method of any one of claims 1-27, wherein the first loading solution comprises:
between 20 U and 80 U insulin per 1 L;
between 4 mg and 16 mg dexamethasone per 1 L;
between 25 g and 100 g 35 kDa PEG per 1 L;
between 25 mL and 100 mL glycerol;
between 20 g and 80 g Trehalose dihydrate; and
UW.

### Claim 29 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28)

The method of any one of claims 1-28, wherein the first loading solution comprises:
about 40 U insulin per 1 L;
about 8 mg dexamethasone per 1 L;
about 50 g 35 kDa PEG per 1 L;
about 50 mL glycerol;
about 37.83 g Trehalose dihydrate; and
UW.

### Claim 30 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29)

The method of any one of claims 1-29, wherein the second loading solution comprises:
between 20 U and 80 U insulin per 1 L;
between 4 mg and 16 mg dexamethasone per 1 L;
between 25 g and 100 g 35 kDa PEG per 1 L;
between 50 mL and 200 mL glycerol per 1 L;
between 20 g and 80 g trehalose dihydrate per 1 L; and
UW.

### Claim 31 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30)

The method of any one of claims 1-30, wherein the second loading solution comprises:
about 40 U insulin per 1 L;
about 8 mg dexamethasone per 1 L;
about 50 g 35 kDa PEG per 1 L;
about 100 mL glycerol per 1 L;
about 37.8 g trehalose dihydrate per 1 L; and
UW.

### Claim 32 (depends on 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31)

The method of any one of claims 5-31, wherein the unloading solution comprises:
between 5 U and 20 U insulin per 1 L;
between 4 mg and 16 mg dexamethasone per 1 L;
between 4 mL and 16 mL penicillin-streptomycin (5000 U/ml) per 1 L;
between 25 g and 100 g 35 kDa PEG per 1 L;
between 250 mg and 1000 mg 6-Hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid per 1 L;
between 25 mL and 100 mL 25% human albumin per 1 L;
between 25 mL and 100 mL glycerol per 1 L;
between 20 g and 80 g trehalose dihydrate per 1 L; and
Williams' medium E

### Claim 33 (depends on 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32)

The method of any one of claims 5-32, wherein the unloading solution comprises:
between 5 U and 20 U insulin per 1 L;
between 4 mg and 16 mg dexamethasone per 1 L;
between 4 mL and 16 mL penicillin-streptomycin (5000 U/ml) per 1 L;
between 25 g and 100 g 35 kDa PEG per 1 L;
between 250 mg and 1000 mg 6-Hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid per 1 L;
between 25 mL and 100 mL 25% human albumin per 1 L;
between 25 mL and 100 mL glycerol per 1 L;
between 20 g and 40 g trehalose dihydrate per 1 L; and
Williams' medium E.

### Claim 34 (depends on 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33)

The method of any one of claims 5-33, wherein the post-supercooling recovery solution comprises:
between 5 U and 20 U insulin per 1 L;
between 4 mg and 16 mg dexamethasone per 1 L;
between 2500 U and 10,000 U sodium heparin per 1 L;
between 4 mL and 16 mL penicillin-streptomycin (5,000 U/ml) per 1 L;
between 250 mg and 1000 mg 6-Hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid per 1 L;
between 25 mL and 100 mL 25% human albumin per 1 L;
between 10 g and 40 g 35 kDa PEG per 1 L; and
Williams' medium E.

### Claim 35 (depends on 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34)

The method of any one of claims 5-34, wherein the post-supercooling recovery solution comprises:
about 10 U insulin per 1 L;
about 8 mg dexamethasone per 1 L;
about 5000 U sodium heparin per 1 L;
about 8 mL penicillin-streptomycin (5,000 U/ml) per 1 L;
about 500 mg 6-Hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid per 1 L;
about 50 mL 25% human albumin per 1 L;
about 20 g 35 kDa PEG per 1 L; and
Williams' medium E.

### Claim 36 (depends on 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35)

The method of any one of claims 3-35, wherein:
between 20 g and 80 g 3-OMG per 1 L and between 100 U and 400 U insulin per 1 L are added to the pre-supercooling recovery solution during the perfusion step at the sub-normothermic temperature.

### Claim 37 (depends on 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36)

The method of any one of claim 3-36, wherein:
about 38.8 g 3-OMG per 1 L and about 190 U insulin per 1 L are added to the pre-supercooling recovery solution during the perfusion step at the sub-normothermic temperature.

### Claim 38 (depends on 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35)

The method of any one of claims 3-35, wherein the pre-supercooling recovery solution is replaced with a pre-supercooling recovery solution additionally comprising between 20 g and 80 g 3-OMG per 1 L and between 100 U and 400 U insulin per 1 L.

### Claim 39 (depends on 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35)

The method of any one of claims 3-35, wherein the pre-supercooling recovery solution is replaced with a pre-supercooling recovery solution additionally comprising about 38.8 g 3-OMG per 1 L and about 190 U insulin per 1 L.

### Claim 40 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39)

The method of any one of claims 1-39, wherein:
steps (a) and (b), combined, are performed for a duration of approximately 1 hour.

### Claim 41 (depends on 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40)

The method of any one of claims 5-40, wherein:
step (f) is performed for a duration of approximately 10 minute; and/or
step (g) is performed for approximately 3 hours.

### Claim 42 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41)

The method of any one of claims 1-41, wherein
steps (a) and (b) each comprises perfusing the biological sample by single-pass perfusion.

### Claim 43 (depends on 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42)

The method of any one of claims 2-42, wherein the perfusion step at the sub-normothermic temperature comprises perfusing the biological sample by single-pass perfusion followed by recirculation perfusion.

### Claim 44 (depends on 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42)

The method of any one of claims 2-42, wherein the perfusion step at the hypothermic temperature comprises perfusing the biological sample by recirculation perfusion.

### Claim 45 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44)

The method of any one of claims 1-44, wherein all perfusion steps are performed with a perfusion rate that is lower than the perfusion rate of blood that the biological sample would experience in vivo.

### Claim 46 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45)

The method of any one of claims 1-45, wherein the biological sample is a human liver and wherein the human liver is perfused by portal and arterial perfusion at a perfusion rate for step (a) maintained at a level sufficient to obtain perfusion pressure of about 3 mmHg for the portal vein (PV) and about 30 mmHg for the hepatic artery (HA) for a period of time.

### Claim 47 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46)

The method of any one of claims 1-46, wherein the perfusion steps are performed using a pump that generates non-pulsatile flow.

### Claim 48 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47)

The method of any one of claims 1-47, wherein the biological sample is preserved at the subzero temperature for more than 12 hours, e.g., more than 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, or 24 hours.

### Claim 49 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48)

The method of any one of claims 1-48, wherein the container is a surgical isolation bag.

### Claim 50 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49)

The method of any one of claims 1-49, wherein sufficient air is removed from the container by immersing the container containing the biological sample in water or by using a vacuum pump.

### Claim 51 (depends on 3)

The method of claim 3, wherein the biological sample is viable after being recovered from subzero preservation, as determined by measuring one or more of a tissue adenosine triphosphate (ATP) to adenosine monophosphate (AMP) ratio, a tissue ATP to adenosine diphosphate (ADP) ratio, lactate clearance, potassium concentration, urea concentration, aspartate aminotransferase (AST) and alanine aminotransferase (ALT) concentrations, and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL).

### Claim 52 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33)

A system for subzero preserving a biological sample, the system comprising:
a pump;
a solution reservoir;
a heat exchanger;
a hollow fiber oxygenator;
a jacketed bubble trap;
a pressure sensor;
a tubing that serially connects the pump, the solution reservoir, the heat exchanger, the hollow fiber oxygenator, the jacketed bubble trap, and the pressure sensor;
and a computer control unit that operates the system to perform any of the perfusion steps described in claims 1-33.

### Claim 53

A loading solution for preconditioning a biological sample for subzero preservation, the solution comprising, per 1 L volume:
between 25 g and 100 g 35 kDa PEG;
between 25 mL and 200 mL glycerol;
between 20 g and 80 g trehalose; and
UW.

### Claim 54 (depends on 53)

The loading solution of claim 53, further comprising, per 1 L volume:
between 20 U and 80 U insulin; and
between 4 mg and 16 mg dexamethasone.

### Claim 55 (depends on 54)

The loading solution of claim 54, wherein the loading solution comprises:
about 40 U insulin per 1 L;
about 8 mg dexamethasone per 1 L;
about 50 g 35 kDa PEG per 1 L;
about 50 mL glycerol;
about 37.83 g Trehalose dihydrate; and
UW.

### Claim 56 (depends on 53)

The loading solution of claim 53, wherein the loading solution comprises:
about 40 U insulin per 1 L;
about 8 mg dexamethasone per 1 L;
about 50 g 35 kDa PEG per 1 L;
about 100 mL glycerol per 1 L;
about 37.8 g trehalose dihydrate per 1 L; and
UW.

### Claim 57

A post-supercooling recovery solution comprising:
between 5 U and 20 U insulin per 1 L;
between 4 mg and 16 mg dexamethasone per 1 L;
between 2500 and 10,000 U sodium heparin per 1 L;
between 4 mL and 16 mL penicillin-streptomycin (5,000 U/ml) per 1 L;
between 250 mg and 1,000 mg 6-Hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid per 1 L;
between 25 mL and 100 mL 25% human albumin per 1 L;
between 10 g and 40 g 35 kDa PEG per 1 L; and
Williams' medium E.

### Claim 58 (depends on 57)

The post-supercooling recovery solution of claim 57, wherein the solution comprises:
about 10 U insulin per 1 L;
about 8 mg dexamethasone per 1 L;
about 5000 U sodium heparin per 1 L;
about 8 mL penicillin-streptomycin (5,000 U/ml) per 1 L;
about 500 mg 6-Hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid per 1 L;
about 50 mL 25% human albumin per 1 L;
about 20 g 35 kDa PEG per 1 L; and
Williams' medium E.
